Daiwa Securities Group »

Aeglea Biotherapeutics shares owned by Daiwa Securities Group

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Daiwa Securities Group from 13F filings

Historical chart of Daiwa Securities Group investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Daiwa Securities Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Daiwa Securities Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0k 206 14.56
2025-06-30 $3.0k 206 14.56
2025-03-31 $3.0k 206 14.56

More positions owned by Daiwa Securities Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Welltower Inc Com reit (WELL)
Netflix Common stock (NFLX)
Digital Realty Trust (DLR)
Crowdstrike Hldgs Cl A (CRWD)
Servicenow (NOW)
Prologis (PLD)
Invitation Homes (INVH)
Global X Fds Conscious Cos (KRMA)

View all positions for Daiwa Securities Group

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics